Treatment of Hypothyroidism with Combinations of Levothyroxine plus Liothyronine
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
CONTEXT: Combined infusion of levothyroxine plus liothyronine, as opposed to levothyroxine alone, is the only way of restoring the concentrations of circulating TSH, T4, and T3 as well as those of both T4 and T3 in all tissues of thyroidectomized rats. Considering the substantial differences in thyroid hormone secretion, transport, and metabolism between rats and humans, whether or not combined levothyroxine plus liothyronine replacement therapy has advantages over treatment with levothyroxine alone in hypothyroid patients is still questioned. EVIDENCE ACQUISITION: We conducted a systematic review of all the published controlled studies comparing treatment with levothyroxine alone with combinations of levothyroxine plus liothyronine in hypothyroid patients, identified through the Entrez-PubMed search engine. EVIDENCE SYNTHESIS: Nine controlled clinical trials were identified that compared treatment with levothyroxine alone and treatment with combinations of levothyroxine plus liothyronine and included a sufficient number of adult hypothyroid patients to yield meaningful results. In only one study did the combined therapy appear to have beneficial effects on the mood, quality of life, and psychometric performance of the patients over levothyroxine alone. These results have not been confirmed by later studies using either T3 substitution protocols or approaches with fixed combinations of levothyroxine plus liothyronine, including those based on the physiological proportion in which T3 and T4 are secreted by the human thyroid. However, in some of these studies the patients preferred levothyroxine plus liothyronine combinations, for reasons not explained by changes in the psychological and psychometric tests employed. Yet patients' preference should be balanced against the possibility of adverse events resulting from the addition of liothyronine to levothyroxine, even in the small doses used in these studies. CONCLUSIONS: Until clear advantages of levothyroxine plus liothyronine are demonstrated, the administration of levothyroxine alone should remain the treatment of choice for replacement therapy of hypothyroidism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, systematic reviews and metaanalyses of 18 trials of combination levothyroxine-liothyronine replacement found no clear benefit over levothyroxine monotherapy.12,13”
From Hypothyroidism (2024) · cites this paper as [13]
In the citing paper
“Furthermore, four systematic reviews and metaanalyses 12,13,180,181 of these trials found no clear benefit of combination levothyroxineliothyronine therapy over levothyroxine monotherapy in terms of mood, healthrelated quality of life, or cognitive function.”
From Hypothyroidism (2024) · cites this paper as [13]
In the citing paper
“This combined therapy aims to more closely mimic the natural secretion of the thyroid gland, potentially restoring physiological levels of T3 and T4 across various tissues [28].”
In the citing paper
“This may constitute a bias, as the benefit of combination therapy in one trial was observed only in the thyroid cancer patients and not in patients with autoimmune thyroiditis [48,49] .”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [49]
In the citing paper
“Indeed, serum free T4 to free T3 ratios in patients randomized to receive L-T4 monotherapy range from 4.0 to 5.5 ( table 3 ), higher than the value of 3.3 observed in healthy controls [49] .”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [49]
Citations
Cites
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Ingbar, S. H. (1965) · Archives of Internal Medicine · doi:10.1001/archinte.1965.03870060154035 · Cited by 1,743
Baskin, H. J., Cobin, R. H., Duick, D. S., Gharib, H., Guttler, R. B., Kaplan, M. M., Segal, R. L., Garber, J. R., Hamilton Jr, C. R., Handelsman, Y., et al. (2002) · Endocrine Practice · doi:10.4158/1934-2403-8.6.457 · Cited by 673
Saravanan, P., Chau, W. ‐., Roberts, N., Vedhara, K., Greenwood, R., & Dayan, C. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01654.x · Cited by 514 · cited 2×
“(30, 32) was greeted with considerable interest not only for scientific reasons but also for hypothyroid patients; combined levothyroxine plus liothyronine replacement was considered the answer to the relatively frequent complaint (35) of the persistence, with levothyroxine alone, of hypothyroid symptoms despite norma…”
BackgroundBunevičius, R., Kažanavičius, G., Žalinkevičius, R., & Prange, A. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400603 · Cited by 482 · cited 7×
“(30, 32), it would appear that T3 substitution has a minor role, if any, in thyroid replacement therapy (14, 31, 41).”
BackgroundMethodResultInfluentialAdvances in Our Understanding of Thyroid Hormone Action at the Cellular Level*
OPPENHEIMER, J. H., SCHWARTZ, H. L., MARIASH, C. N., KINLAW, W. B., WONG, N. C. W., & FREAKE, H. C. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-3-288 · Cited by 476
Bianco, A. C. (2002) · Endocrine Reviews · doi:10.1210/er.23.1.38 · Cited by 423
Hennemann, G., Docter, R., Friesema, E. C. H., de Jong, M., Krenning, E. P., & Visser, T. J. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.4.0435 · Cited by 394
Fish, L. H., Schwartz, H. L., Cavanaugh, J., Steffes, M. W., Bantle, J. P., & Oppenheimer, J. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703263161302 · Cited by 353
Escobar-Morreale, H. F., Obregón, M. J., Escobar del Rey, F., & Morreale de Escobar, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118353 · Cited by 287
Self-citation
Cited by
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
“(525) also concluded that data on benefits of combination treatment on psychological outcomes were heterogeneous and not reproducible, and that the treatment preference for combination treatment was not explained based on results of psychologic or psychometric tests.”
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
“Why do some patients prefer combination therapy to Lthyroxine monotherapy (133)? Some insight into the latter question may be gained from a large-scale study of L-thyroxine and L-triiodothyronine combination therapy in which different responses were observed in patients with different genetic subtypes of type 2 deiodi…”
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053
“…combination therapy (132), have re-ad-dressed the benefits of synthetic L-thyroxine and L-triio-dothyronine combination therapy but have largely failed to confirm an advantage of this approach to improve cognitive or mood outcomes in hypothyroid individuals treated with L-thyroxine alone (133,134).”
The Thyroid‐Brain Interaction in Thyroid Disorders and Mood Disorders
Bauer, M., Goetz, T., Glenn, T., & Whybrow, P. C. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01774.x · Cited by 438
2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism
Wiersinga, W. M., Duntas, L., Fadeyev, V., Nygaard, B., & Vanderpump, M. P. J. (2012) · European Thyroid Journal · doi:10.1159/000339444 · Cited by 437
Grozinsky-Glasberg, S., Fraser, A., Nahshoni, E., Weizman, A., & Leibovici, L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0448 · Cited by 296
“It was later suggested that this benefit was associated with the cause of hypothyroidism and that only athyreotic thyroid cancer patients benefited from combination therapy, whereas patients with autoimmune thyroiditis did not (13, 38).”
BackgroundTreatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
Triiodothyronine Levels in Athyreotic Individuals During Levothyroxine Therapy
Jonklaas, J. (2008) · JAMA · doi:10.1001/jama.299.7.769 · Cited by 216
“These studies have included randomized placebo-controlled studies,(21-24) randomized parallel-design studies,(25,26) crossover studies,(19,20,27-32) studies focusing on patients with both hypothyroidismanddepressive symptoms,(22,23) a study of patients with thyroid cancer,(32) and recent meta-analyses.(15,33) Some of…”
BackgroundTreatment for primary hypothyroidism: current approaches and future possibilities
Vaidya, B., Chakera, & Pearce (2011) · Drug Design, Development and Therapy · doi:10.2147/dddt.s12894 · Cited by 199
“This is in contrast with human physiological thyroxine and triiodothyronine ratio of 14:1, 56 and therefore the thyroid extract contains a supraphysiological amount of triiodothyronine.”
Overt and Subclinical Hypothyroidism: Who to Treat and How
Khandelwal, D., & Tandon, N. (2012) · Drugs · doi:10.2165/11598070-000000000-00000 · Cited by 199
West, P. R., Weir, A. M., Smith, A. M., Donley, E. L. R., & Cezar, G. G. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.05.007 · Cited by 185
Hoang, T. D., Olsen, C. H., Mai, V. Q., Clyde, P. W., & Shakir, M. K. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4107 · Cited by 151
Position Stand on Androgen and Human Growth Hormone Use
Hoffman, J. R., Kraemer, W. J., Bhasin, S., Storer, T., Ratamess, N. A., Haff, G. G., Willoughby, D. S., & Rogol, A. D. (2009) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e31819df2e6 · Cited by 139
“Unsupervised use of thyroid drugs can disrupt the hypothalamic-pituitary-thyroid axis and produce negative side effects such as bone and skeletal muscle catabolism, heart palpitations, agitation, shortness of breath, irregular heartbeat, sweating, nausea, irritability, tremors, restlessness, and headaches (113,167).”
BackgroundThyroid Function Abnormalities in HIV-Infected Patients
Mayer, K. H., Hoffmann, C. J., & Brown, T. T. (2007) · Clinical Infectious Diseases · doi:10.1086/519978 · Cited by 132
Taylor, P. N., Medici, M. M., Hubalewska-Dydejczyk, A., & Boelaert, K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01614-3 · Cited by 128
“12,13 Reference ranges might be dynamic rather than static.”
Combination Treatment with T4 and T3: Toward Personalized Replacement Therapy in Hypothyroidism?
Biondi, B., & Wartofsky, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3399 · Cited by 124
Gender differences in thyroid system function: relevance to bipolar disorder and its treatment
Bauer, M., Glenn, T., Pilhatsch, M., Pfennig, A., & Whybrow, P. C. (2014) · Bipolar Disorders · doi:10.1111/bdi.12150 · Cited by 119
Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism
Wiersinga, W. M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.258 · Cited by 114
Thyroid disease and mental disorders: cause and effect or only comorbidity?
Bunevičius, R., & Prange, A. J. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283387b50 · Cited by 136
Saravanan, P., Visser, T. J., & Dayan, C. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0414 · Cited by 90
“Recently several studies of thyroid hormone replacement therapy reported that the combination of T4 and T3 is not superior to T4 alone (7, 8).”
BackgroundÅsvold, B. O., Vatten, L. J., Bjøro, T., Bauer, D. C., Bremner, A., Cappola, A. R., Ceresini, G., den Elzen, W. P. J., Ferrucci, L., Franco, O. H., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.0930 · Cited by 78
“SHIP,30 2010 Adults living in Western Pomerania, Germany 2738 45 (20-81) 50.”
InfluentialChaalal, A., Poirier, R., Blum, D., Laroche, S., & Enderlin, V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1111-z · Cited by 83
“Interestingly, recent data showed that combined L-T4 and L-T3 administration, by normalizing all TH-dependent measures including tissue T3 levels, benefits to hypothyroid patients with psychological symptoms, and/or cognitive dysfunction [10, 70, 71].”
BackgroundLiothyronine use in a 17 year observational population‐based study ‐ the tears study
Leese, G. P., Soto‐Pedre, E., & Donnelly, L. A. (2016) · Clinical Endocrinology · doi:10.1111/cen.13052 · Cited by 75
Hildebrandt, T., Langenbucher, J. W., Carr, S. J., & Sanjuan, P. M. (2007) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.116.4.717 · Cited by 83
Thyroxine replacement: a clinical endocrinologist’s viewpoint
Eligar, V, Taylor, P., Okosieme, O., Leese, G., & Dayan, C. (2016) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563216642255 · Cited by 72
Santoro, N. F., Braunstein, G. D., Butts, C. L., Martin, K. A., McDermott, M., & Pinkerton, J. V. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1271 · Cited by 86
Djurovic, M. N., Pereira, A. M., Smit, J. W. A., Vasović, O., Damjanovic, S. S., Jemuovic, Z., Pavlović, D. M., Miljić, D., Pekić, S., Stojanović, M., et al. (2018) · Endocrine · doi:10.1007/s12020-018-1649-6 · Cited by 83
Valizadeh, M., Seyyed-Majidi, M. R., Hajibeigloo, H., Momtazi, S., Musavinasab, N., & Hayatbakhsh, M. R. (2009) · Endocrine Research · doi:10.1080/07435800903156340 · Cited by 65
The emergence of levothyroxine as a treatment for hypothyroidism
Hennessey, J. V. (2017) · Endocrine · doi:10.1007/s12020-016-1199-8 · Cited by 66
Papi, G., Uberti, E. C. D., Betterle, C., Carani, C., Pearce, E. N., Braverman, L. E., & Roti, E. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32803577e7 · Cited by 77
Dayan, C., & Panicker, V. (2018) · Thyroid Research · doi:10.1186/s13044-018-0045-x · Cited by 62
Millan-Alanis, J. M., González-González, J. G., Flores-Rodríguez, A., Singh Ospina, N., Maraka, S., Moreno-Peña, P. J., Brito, J. P., González-Velázquez, C., & Rodríguez-Gutiérrez, R. (2021) · Thyroid® · doi:10.1089/thy.2021.0270 · Cited by 60
“From 2000 to 2009, several clinical trials and a meta-analysis compared LT4/LT3 combined with LT4 monotherapy without evidence of superiority of any treatment modality (2,5,16,17–20).”
Joffe, R. T., Brimacombe, M., Levitt, A. J., & Stagnaro-Green, A. (2007) · Psychosomatics · doi:10.1176/appi.psy.48.5.379 · Cited by 57
Yaniv, D., Vainer, I., Amir, I., Robenshtok, E., Hirsch, D., Watt, T., Hilly, O., Shkedy, Y., Shpitzer, T., Bachar, G., et al. (2022) · Journal of Surgical Oncology · doi:10.1002/jso.26983 · Cited by 55
“Nevertheless, no single TSH concentration is likely to adequately reflect an euthyroid condition in every tissue implicating intrinsic imperfections of thyroxine replacement therapy.(20) These imperfections might provide an explanation as to why LT4 therapy following thyroidectomy has a detrimental impact on QOL and b…”
BackgroundHennessey, J. V., & Espaillat, R. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13062 · Cited by 49
Fallahi, P., Ferrari, S. M., Ruffilli, I., Ragusa, F., Biricotti, M., Materazzi, G., Miccoli, P., & Antonelli, A. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1227782 · Cited by 48
“choice for replacement therapy of hypothyroidism [22].”
Rajab, N. M. A., Ukropina, M., & Čakić-Milošević, M. (2015) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2015.05.006 · Cited by 55
Hormone Replacement After Thyroid and Parathyroid Surgery
Schäffler, A. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0827 · Cited by 68
Do we need still more trials on T4 and T3 combination therapy in hypothyroidism?
Wiersinga, W. M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0879 · Cited by 45
“Indeed, the serum FT4‐FT3 ratio in patients randomized to receive T4 monotherapy in the meta-analysis ranges from 4.0 to 6.7 (7, 8, 10, 11, 13), higher than the value of 3.3 observed in controls ( 18 ).”
BackgroundInfluentialPhysician Choice of Hypothyroidism Therapy: Influence of Patient Characteristics
Jonklaas, J., Tefera, E., & Shara, N. (2018) · Thyroid · doi:10.1089/thy.2018.0325 · Cited by 41
Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options
Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2019) · Drugs in Context · doi:10.7573/dic.212597 · Cited by 41
Guglielmi, R., Frasoldati, A., Zini, M., Grimaldi, F., Gharib, H., Garber, J. R., & Papini, E. (2016) · Endocrine Practice · doi:10.4158/ep161308.or · Cited by 39
Persistent hypothyroid symptoms in a patient with a normal thyroid stimulating hormone level
Jonklaas, J. (2017) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000355 · Cited by 38
T 3 Augmentation in Major Depressive Disorder: Safety Considerations
Rosenthal, L. J., Goldner, W. S., & O’Reardon, J. P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10030402 · Cited by 42
Time for a reassessment of the treatment of hypothyroidism
Midgley, J. E. M., Toft, A. D., Larisch, R., Dietrich, J. W., & Hoermann, R. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0365-4 · Cited by 36
Liothyronine Use in Hypothyroidism and its Effects on Cancer and Mortality
Planck, T., Hedberg, F., Calissendorff, J., & Nilsson, A. (2021) · Thyroid® · doi:10.1089/thy.2020.0388 · Cited by 35
“The majority of randomized controlled trials have shown no overall benefit of combined treatment compared with LT4 treatment alone, a conclusion that is supported by five EFFECTS OF TRIIODOTHYRONINE TREATMENT meta-analyses (21–25).”
Thyroid hormone replacement: current status and challenges
Okosieme, O. E. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.600307 · Cited by 35
“For example, humans have higher concentrations of thyroidbinding globulins and exhibit a greater capacity for buffering and release of thyroid hormones than rats (reviewed in [78]).”
BackgroundInfluentialRegalbuto, C., Maiorana, R., Alagona, C., Paola, R. D., Cianci, M., Alagona, G., Sapienza, S., Squatrito, S., & Pezzino, V. (2007) · Thyroid · doi:10.1089/thy.2006.0084 · Cited by 32
“The physiological T4 = T3 molar ratio in thyroid secretion is approximately 14:1 in adults; for this reason the ideal thyroid hormone preparation should contain LT4 and LT3 in a similar molar proportion (44).”
Santini, F., Giannetti, M., Ricco, I., Querci, G., Saponati, G., Bokor, D., Rivolta, G., Bussi, S., Braverman, L. E., Vitti, P., et al. (2014) · Endocrine Practice · doi:10.4158/ep13331.or · Cited by 31
Del Duca, S. C., Santaguida, M. G., Brusca, N., Gatto, I., Cellini, M., Gargano, L., Verga Falzacappa, C., Frattaroli, F. M., Virili, C., & Centanni, M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0314 · Cited by 31
Prescribing Therapy for Hypothyroidism: Influence of Physician Characteristics
Jonklaas, J., Tefera, E., & Shara, N. (2019) · Thyroid · doi:10.1089/thy.2018.0369 · Cited by 31
Thyroid Cancer in Young Adults
Ying, A. K., Huh, W. W., Bottomley, S. J., Evans, D. B., & Waguespack, S. G. (2009) · Seminars in Oncology · doi:10.1053/j.seminoncol.2009.03.009 · Cited by 32
L-T 4 Bioequivalence and Hormone Replacement Studies via Feedback Control Simulations
Eisenberg, M. C., Samuels, M. H., & DiStefano, J. J. (2006) · Thyroid · doi:10.1089/thy.2006.0144 · Cited by 31
Escobar-Morreale, H. F., Botella-Carretero, J. I., & Morreale de Escobar, G. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.10.004 · Cited by 30
Substitution von Schilddrüsenhormonen
Gärtner, R., & Reincke, M. (2008) · Der Internist · doi:10.1007/s00108-008-2109-9 · Cited by 32
Thyroid–Brain Interactions in Neuropsychiatric Disorders
Bunevičius, R., & Prange, A. J. (2010) · Springer eBooks · doi:10.1007/978-4-431-53871-4_2 · Cited by 28
BNP as a New Biomarker of Cardiac Thyroid Hormone Function
Wang, K., Ojamaa, K., Samuels, A., Gilani, N., Zhang, K., An, S., Zhang, Y., Tang, Y., Askari, B., & Gerdes, A. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00729 · Cited by 29
Planck, T., Lantz, M., Perros, P., Papini, E., Attanasio, R., Nagy, E. V., & Hegedüs, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.795111 · Cited by 23
Sella, A., Hercbergs, A. H., Hanovich, E., & Kovel, S. (2012) · Chemotherapy · doi:10.1159/000337079 · Cited by 25
Springer, D. (2012) · InTech eBooks · doi:10.5772/1215 · Cited by 26
“…replacement with a combination of T4 and T3, in comparison with T4 monotherapy, improves mental functioning in some but not all hypothyroid patients (Bunevicius et al., 1999; Nygaard et al., 2009), and most of the patients subjectively prefer combined treatment (Escobar-Morreale et al., 2005).”
BackgroundAssociation of hypothyroidism with acute COVID-19: a systematic review
Malik, J., Zaidi, S. M. J., Waqar, A. U., Khawaja, H. F., Malik, A. A., Ishaq, U., Rana, A. S., & Awan, A. H. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1968830 · Cited by 22
Gostomski, I., Braun, R., & Huber, C. G. (2008) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-008-1920-4 · Cited by 22
Combination Thyroid Hormone Replacement; Knowns and Unknowns
Taylor, P. N., Eligar, V., Muller, I., Scholz, A., Dayan, C., & Okosieme, O. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00706 · Cited by 21
L-T 4 Bioequivalence and Hormone Replacement Studies via Feedback Control Simulations
Eisenberg, M., Samuels, M., & DiStefano, J. J. (2006) · Thyroid · doi:10.1089/thy.2006.16.1279 · Cited by 31
Levothyroxine replacement therapy after thyroid surgery.
Verhaert, N., Poorten, V. V., Delaere, P., Bex, M., & Debruyne, F. (2006) · PubMed · Cited by 24
Yeh, S., Lin, J.-F., & Chen, B. (2021) · Molecules · doi:10.3390/molecules26113178 · Cited by 20
“Studies have shown that combined therapy with liothyronine improved the treatment of hypothyroidism [80,81].”
BackgroundIn vitro permeation of levothyroxine across the skin
Padula, C., Pappani, A., & Santi, P. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.08.004 · Cited by 17
Does Combination T4 And T3 Therapy Make Sense?
McDermott, M. T. (2012) · Endocrine Practice · doi:10.4158/ep12076.ra · Cited by 18
Fitzgerald, S. P., & Falhammar, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.920854 · Cited by 20
“Thus far studies have generally been negative (105), but this has not completely quelled interest (104).”
BackgroundAkçay, T., Turan, S., Güran, T., Ünlügüzel, G., Haklar, G., & Bereket, A. (2010) · Hormone Research in Paediatrics · doi:10.1159/000277627 · Cited by 15
“Nevertheless, in some of these studies, the patients preferred L-T4 plus liothyronine combinations over L-T4 alone, for reasons not explained by changes in the psychological and psychometric tests employed, or the biological end-points that were measured. TSH levels, however, were usually lower during combination trea…”
ResultCarmichael, J. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00010-6 · Cited by 14
Neu, V., Bielow, C., Schneider, P., Reinert, K., Stuppner, H., & Huber, C. G. (2013) · Analytical Chemistry · doi:10.1021/ac303404e · Cited by 14
The pharmacological treatment of obesity: Past, present and future
Simonyi, G., Pados, G., Medvegy, M., & Bedros, J. R. (2012) · Orvosi Hetilap · doi:10.1556/oh.2012.29317 · Cited by 16
Mazzaferri, E. L. (2006) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70611-4 · Cited by 12
Nassar, M., Hassan, A., Ramadan, S., Desouki, M. T., Hassan, M. A., & Chaudhuri, A. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01612-6 · Cited by 12
Pushkaran, A. C., Kumaran, K., Ann Maria, T., Biswas, R., & Mohan, C. G. (2023) · Molecular Informatics · doi:10.1002/minf.202200254 · Cited by 11
Dose administration time from before breakfast to before dinner affect thyroid hormone levels?
Ala, S., Akha, O., Kashi, Z., Asgari, H., Bahar, A., & Sasanpour, N. (2015) · PubMed Central · Cited by 13
Latrofa, F., & Pinchera, A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-517-6_7 · Cited by 15
LT4 and Slow Release T3 Combination: Optimum Therapy for Hypothyroidism?
Azizi, F., Amouzegar, A., Mehran, L., & Abdi, H. (2020) · Intern J Endocrinol Metab · doi:10.5812/ijem.100870 · Cited by 14
Mazzaferri, E. L. (2006) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70362-7 · Cited by 10
Ala, S., Akha, O., Kashi, Z., Bahar, A., Rad, H. A., Sasanpour, N., & Shiva, A. (2015) · International Journal of Endocrinology · doi:10.1155/2015/156375 · Cited by 10
“Combination therapy with levothyroxine and liothyronine (triiodothyronine or T3) has been suggested as an alternative; however the present evidence from clinical trials does not show any benefit for the combination therapy compared with monotherapy with levothyroxine [3–7].”
ResultNHG-Standaard Schildklieraandoeningen
Wessels, P., van Rijswijk, E., Boer, M. A., & van Lieshout, J. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6614-9_86 · Cited by 9
Treatment of Hypothyroidism: Possibilities on the Horizon
Jonklaas, J., Burman, K. D., & Bianco, A. C. (2013) · Thyroid · doi:10.1089/thy.2013.0171 · Cited by 10
Krysiak, R. G., Marek, B., & Okopień, B. (2018) · Endokrynologia Polska · doi:10.5603/ep.a2018.0005 · Cited by 9
“There are conflicting animal and human data indicating that the addition of liothyronine to levothyroxine therapy may reverse these symptoms and improve quality of life [10, 11].”
Carmichael, J. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10010-0 · Cited by 8
Ni, W.-C., Kong, S., Lin, K., Huang, Y., Li, J., Shi, S., Lu, Y.-C., Cheng, L., Chen, C., & Zhou, H. (2023) · European journal of medical research · doi:10.1186/s40001-023-01149-9 · Cited by 8
“Serum TSH levels indicate thyroid-pituitary feedback, but may not reliably reflect thyroid function in all organs [39].”
BackgroundEthical Issues in the Management of Thyroid Disease
Rosenthal, M. S. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2014.02.013 · Cited by 6
Pappy, A. L., Oyesiku, N. M., & Ioachimescu, A. G. (2016) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/2324709616661834 · Cited by 8
“Furthermore, Escobar-Morreale’s systematic review showed that the benefits of combination T4/T3 therapy on psychological outcomes were heterogeneous and not reproducible.(24) Our patient was converted from a daily dose of 175 μg LT4 to a lower dose of 57/13.”
BackgroundRadioiodine in the Management of Benign Thyroid Disease
Ahmad, S., & Shirazi, N. (2018) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/13094_29 · Cited by 7
Kerrigan, L., Stewart, S. A., Domínguez‐Robles, J., Brady, A. J., Ammar, A. A., Donnelly, R. F., Permana, A. D., & Larrañeta, E. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104861 · Cited by 11
Akkaya, E. C., Koç, B., Dalkiran, B., Calis, G., Dayı, A., & Kayatekin, B. M. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114752 · Cited by 6
Prognostic Value of Normal Thyroid Stimulating Hormone in Long-Term Mortality in Patients With STEMI
Sun, L., Xiao, K., Miao, Z., Zhang, Y., Jin, S., Shi, N., Zhang, H., Zhao, T., & Li, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.806997 · Cited by 5
“Evidence shows that although the serum TSH level reflects thyroid–pituitary feedback, it might not be efficient enough to show thyroid status in every organ (33).”
BackgroundLowe, J. C. (2009) · Cited by 6
Pepper, G. M., & Casanova-Romero, P. Y. (2014) · Cited by 7
Agu, R. U., Mactavish, J., K. Yeung, P., & Imran, S. A. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1115012 · Cited by 4
“apy.[4,5] An animal thyroid (mostly pig) preparation, Armour, is also available; however, its use remains limited due to concerns regarding batch-to-batch variability and lack of any significant advantage of desiccated thyroid extract over synthetic T4.”
BackgroundKowalcze, K. E., Kula-Gradzik, J., Błaszczyk, A., & Krysiak, R. G. (2025) · Nutrients · doi:10.3390/nu17132091 · Cited by 5
Acquired hypothyroidism after switching from thyroid USP to levothyroxine
Jellinger, P. S. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80055-9 · Cited by 4
Varlamov, E. V., & Fleseriu, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00019-6 · Cited by 6
Potential uses of T3 in the treatment of human disease
Danzi, S. E., & Klein, I. L. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80052-3 · Cited by 6
Metadata
- Authors
- Escobar-Morreale, H. F., Botella-Carretero, J. I., del Rey, F. E., & de Escobar, G. M.
- Affiliations
- Hospital Universitario Ramón y Cajal (ES)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-08
- Volume
- 90
- Issue
- 8
- Pages
- 4946-4954
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2081588773
- Cited by
- 160
- References
- 49
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 4 · 2019: 6 · 2018: 10 · 2017: 4 · 2016: 9 · 2015: 8 · 2014: 8 · 2013: 5 · 2012: 12
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Funders
- Comunidad de Madrid
- Instituto de Salud Carlos III
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- hypothyroidism, levothyroxine, liothyronine, T4/T3 ratio, thyroid hormone replacement, quality of life, mood, psychometric performance, patient preferences, adverse events
- MeSH terms
- Drug Therapy, Combination, Humans, Hypothyroidism, Thyroxine, Triiodothyronine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.